Radiation Dose Prescription for Non-Small-Cell Lung Cancer According to Normal Tissue Dose Constraints: An In Silico Clinical Trial

International Journal of Radiation Oncology Biology Physics

Volumn 71, Issue 4, 2008, Pages 1103-1110

  van Baardwijk, Angela ^a   Bosmans, Geert ^a   Bentzen, Søren M ^b   Boersma, Liesbeth ^a   Dekker, André ^a   Wanders, Rinus ^a   Wouters, Bradly G ^a   Lambin, Philippe ^a   De Ruysscher, Dirk ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Iso toxic; Maximal tolerable dose; Mean lung dose; MLD; Non small cell lung cancer; NSCLC; Radiotherapy

Indexed keywords

BIOLOGICAL ORGANS; DOSIMETRY; ELECTROTHERAPEUTICS; PIGMENTS; TUMORS;

ACCELERATED FRACTIONATION; CLINICAL TRIALS; IN-SILICO; NON-SMALL CELL LUNG CANCER (NSCLC); NORMAL TISSUES; RADIATION DOSE; SPINAL CORDS; TOTAL DOSE; TREATMENT PLANNING; TUMOR CONTROL PROBABILITY (TCP);

TISSUE;

ARTICLE; CANCER CONTROL; CANCER PATIENT; COMPUTER MODEL; HUMAN; LUNG; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MAXIMUM TOLERATED DOSE; PRESCRIPTION; PRIORITY JOURNAL; PROBABILITY; RADIATION DOSE; RADIATION DOSE FRACTIONATION; SPINAL CORD; STATISTICAL SIGNIFICANCE; TREATMENT PLANNING;

CARCINOMA, NON-SMALL-CELL LUNG; COMPUTER SIMULATION; DOSE FRACTIONATION; HUMANS; LUNG NEOPLASMS; MODELS, BIOLOGICAL; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; REFERENCE VALUES; TREATMENT OUTCOME;

EID: 45449103257     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.11.028     Document Type: Article

References (49)

1. Le Chevalier T., Arriagada R., Quoix E., et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: First analysis of a randomized trial in 353 patients. J Natl Cancer Inst 83 (1991) 417-423
2. Qiao X., Tullgren O., Lax I., et al. The role of radiotherapy in treatment of stage I non-small cell lung cancer. Lung Cancer 41 (2003) 1-11
3. Saunders M., Dische S., Barrett A., et al., CHART Steering Committee. Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. Radiother Oncol 52 (1999) 137-148
4. Sause W., Kolesar P., Taylor S.I., et al. Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group. Chest 117 (2000) 358-364
5. Belderbos J.S., Heemsbergen W.D., De Jaeger K., et al. Final results of a Phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 66 (2006) 126-134
6. Dillman R.O., Seagren S.L., Propert K.J., et al. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. N Engl J Med 323 (1990) 940-945
7. Kong F.M., Ten Haken R.K., Schipper M.J., et al. High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: Long-term results of a radiation dose escalation study. Int J Radiat Oncol Biol Phys 63 (2005) 324-333
8. Perez C.A., Pajak T.F., Rubin P., et al. Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy: Report by the Radiation Therapy Oncology Group. Cancer 59 (1987) 1874-1881
9. Rowell N.P., and O'Rourke N.P. Concurrent chemoradiotherapy in non-small cell lung cancer. Cochrane Database Syst Rev (2004) CD002140
10. Bradley J. A review of radiation dose escalation trials for non-small cell lung cancer within the Radiation Therapy Oncology Group. Semin Oncol 32 (2005) S111-S113
11. Hayman J.A., Martel M.K., Ten Haken R.K., et al. Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial. J Clin Oncol 19 (2001) 127-136
12. Marks L.B., Garst J., Socinski M.A., et al. Carboplatin/paclitaxel or carboplatin/vinorelbine followed by accelerated hyperfractionated conformal radiation therapy: Report of a prospective phase I dose escalation trial from the Carolina Conformal Therapy Consortium. J Clin Oncol 22 (2004) 4329-4340
13. Martel M.K., Ten Haken R.K., Hazuka M.B., et al. Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients. Lung Cancer 24 (1999) 31-37
14. Baumann M., Herrmann T., Koch R., et al. Continuous hyperfractionated accelerated radiotherapy-weekend less (CHARTWEL) versus conventionally fractionated (CF) radiotherapy in non-small-cell lung cancer (NSCLC): First results of a phase III randomised multicentre trial (ARO 9-71) ECCO 13, 2005. Eur J Cancer 3 Suppl. (2005) 322
15. Curran Jr. W.J. Evolving chemoradiation treatment strategies for locally advanced non-small-cell lung cancer. Oncology (Williston Park) 17 (2003) 7-14
16. Zatloukal P., Petruzelka L., Zemanova M., et al. Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: A randomized study. Lung Cancer 46 (2004) 87-98
17. Fournel P., Robinet G., Thomas P., et al. Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Francais de Pneumo-Cancerologie NPC 95-01 Study. J Clin Oncol 23 (2005) 5910-5917
18. Furuse K., Fukuoka M., Kawahara M., et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol 17 (1999) 2692-2699
19. Huber R.M., Flentje M., Schmidt M., et al. Simultaneous chemoradiotherapy compared with radiotherapy alone after induction chemotherapy in inoperable stage IIIA or IIIB non-small-cell lung cancer: study CTRT99/97 by the Bronchial Carcinoma Therapy Group. J Clin Oncol 24 (2006) 4397-4404
20. Fowler J.F., Tome W.A., Fenwick J.D., et al. A challenge to traditional radiation oncology. Int J Radiat Oncol Biol Phys 60 (2004) 1241-1256
21. Kwa S.L., Lebesque J.V., Theuws J.C., et al. Radiation pneumonitis as a function of mean lung dose: An analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys 42 (1998) 1-9
22. Wang S., Liao Z., Wei X., et al. Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT). Int J Radiat Oncol Biol Phys 66 (2006) 1399-1407
23. Bradley J., Graham M.V., Winter K., et al. Toxicity and outcome results of RTOG 9311: A phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. Int J Radiat Oncol Biol Phys 61 (2005) 318-328
24. Kong F.M., Hayman J.A., Griffith K.A., et al. Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): Predictors for radiation pneumonitis and fibrosis. Int J Radiat Oncol Biol Phys 65 (2006) 1075-1086
25. Rosenzweig K.E., Fox J.L., Yorke E., et al. Results of a phase I dose-escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma. Cancer 103 (2005) 2118-2127
26. De Ruysscher D., Wanders S., Minken A., et al. Effects of radiotherapy planning with a dedicated combined PET-CT-simulator of patients with non-small cell lung cancer on dose limiting normal tissues and radiation dose-escalation: A planning study. Radiother Oncol 77 (2005) 5-10
27. van Baardwijk A., Bosmans G., Dekker A., et al. Time trends in the maximal uptake of FDG on PET scan during thoracic radiotherapy. A prospective study in locally advanced non-small cell lung cancer (NSCLC) patients. Radiother Oncol 82 (2007) 145-152
28. van Der Wel A., Nijsten S., Hochstenbag M., et al. Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: A modeling study. Int J Radiat Oncol Biol Phys 61 (2005) 649-655
29. International Commission on Radiation Units and Measurements. ICRU report 50: Prescribing, recording and reporting photon beam therapy (1993), ICRU, Bethesda
30. Abratt R.P., Bogart J.A., and Hunter A. Hypofractionated irradiation for non-small cell lung cancer. Lung Cancer 36 (2002) 225-233
31. Graham M.V., Pajak T.E., Herskovic A.M., et al. Phase I/II study of treatment of locally advanced (T3/T4) non-oat cell lung cancer with concomitant boost radiotherapy by the Radiation Therapy Oncology Group (RTOG 83-12): Long-term results. Int J Radiat Oncol Biol Phys 31 (1995) 819-825
32. Schultheiss T.E., Kun L.E., Ang K.K., et al. Radiation response of the central nervous system. Int J Radiat Oncol Biol Phys 31 (1995) 1093-1112
33. De Ruysscher D., Wanders S., van Haren E., et al. Selective mediastinal node irradiation based on FDG-PET scan data in patients with non-small-cell lung cancer: A prospective clinical study. Int J Radiat Oncol Biol Phys 62 (2005) 988-994
34. Steel G. Basic clinical radiobiology. 3rd ed. (2002), Hodder Arnold Publications, London
35. Bentzen S.M., Saunders M.I., and Dische S. From CHART to CHARTWEL in non-small cell lung cancer: Clinical radiobiological modeling of the expected change in outcome. Clin Oncol (R Coll Radiol) 14 (2002) 372-381
36. Thames H.D. An "incomplete-repair" model for survival after fractionated and continuous irradiations. Int J Radiat Biol Relat Stud Phys Chem Med 47 (1985) 319-339
37. Ang K.K., Jiang G.L., Guttenberger R., et al. Impact of spinal cord repair kinetics on the practice of altered fractionation schedules. Radiother Oncol 25 (1992) 287-294
38. Bentzen S.M., Ruifrok A.C., and Thames H.D. Repair capacity and kinetics for human mucosa and epithelial tumors in the head and neck: Clinical data on the effect of changing the time interval between multiple fractions per day in radiotherapy. Radiother Oncol 38 (1996) 89-101
39. Senan S., De Ruysscher D., Giraud P., et al. Literature-based recommendations for treatment planning and execution in high-dose radiotherapy for lung cancer. Radiother Oncol 71 (2004) 139-146
40. Goitein M., and Schultheiss T.E. Strategies for treating possible tumor extension: Some theoretical considerations. Int J Radiat Oncol Biol Phys 11 (1985) 1519-1528
41. Lyman J.T., and Wolbarst A.B. Optimization of radiation therapy, III: A method of assessing complication probabilities from dose-volume histograms. Int J Radiat Oncol Biol Phys 13 (1987) 103-109
42. Kutcher G.J., and Burman C. Calculation of complication probability factors for non-uniform normal tissue irradiation: The effective volume method. Int J Radiat Oncol Biol Phys 16 (1989) 1623-1630
43. Lyman J.T. Complication probability as assessed from dose-volume histograms. Radiat Res Suppl 8 (1985) S13-S19
44. Knap M.M., Bentzen S.M., and Overgaard J. Late neurological complications after irradiation of malignant tumors of the testis. Acta Oncol 46 (2007) 497-503
45. Kocak Z., Borst G.R., Zeng J., et al. Prospective assessment of dosimetric/physiologic-based models for predicting radiation pneumonitis. Int J Radiat Oncol Biol Phys 67 (2007) 178-186
46. Belderbos J., Heemsbergen W., Hoogeman M., et al. Acute esophageal toxicity in non-small cell lung cancer patients after high dose conformal radiotherapy. Radiother Oncol 75 (2005) 157-164
47. Takeda K., Nemoto K., Saito H., et al. Dosimetric correlations of acute esophagitis in lung cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys 62 (2005) 626-629
48. Wu K.L., Jiang G.L., Liao Y., et al. Three-dimensional conformal radiation therapy for non-small-cell lung cancer: A phase I/II dose escalation clinical trial. Int J Radiat Oncol Biol Phys 57 (2003) 1336-1344
49. Bradley J., Deasy J.O., Bentzen S., et al. Dosimetric correlates for acute esophagitis in patients treated with radiotherapy for lung carcinoma. Int J Radiat Oncol Biol Phys 58 (2004) 1106-1113